Is Biogen’s RayThera Acquisition a Game-Changer for Immunology?
The global biotechnology industry witnessed another major acquisition announcement in June 2026. Biogen, one of the world’s leading…
Will Servier’s Massive Edgewise Acquisition Pay Off in the Rare Disease Market?
A major strategic transaction has emerged in the global pharmaceutical and biotechnology industry. French pharmaceutical company Servier has…


































































